Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential lysis of tumor target cells displayed by lymphokine activated killer (LAK) cell clones.

International journal of cell cloning - 1 May 1992

Bean P, Agah R, Mazumder A

Abstract excerpt

Lymphokine-activated killer (LAK) cells exhibit major histocompatibility complex (MHC) unrestricted cytolysis against a wide variety of fresh and cultured tumor cells. Because previous work from our laboratory suggested that trypsin treatment of unseparated populations of LAK cells had a differential effect on lysis of different tumors, in this report we analyzed the lytic specificity of LAK cell clones against a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blotting, Southern
Share to Clone Cells
Share to Cytotoxicity, Immunologic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mice, Inbred C57BL

Share to Phenotype

Share to Receptors, Antigen, T-Cell

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 1613270
DOI: 10.1002/stem.5530100310

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential lysis of tumor target cells displayed by lymphokine activated killer (LAK) cell clones.PMID 1613270Read ↗

Establishment of mouse lymphokine-activated killer cell clones and their properties.Semantic proximity Read ↗

Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis.Semantic proximity Read ↗

Cytolytic effector cells against human tumors: distinguishing phenotype and function.Semantic proximity Read ↗

Generation of syngeneic anti-tumour double negative cells (CD4- CD8-), with cytotoxic activity against clones of different MHC class I expression.Semantic proximity Read ↗

High release of tumor necrosis factor alpha, interferon gamma and interleukin-6 by adherent lymphokine-activated killer cells phenotypically derived from T cells.Semantic proximity Read ↗

Lymphokine-activated killer (LAK) cells discriminate between Epstein-Barr virus (EBV)-positive Burkitt's lymphoma cells.Semantic proximity Read ↗

Effector phenotype and immunologic specificity of T-cell-mediated adoptive therapy for a murine tumor that lacks intrinsic immunogenicity.Semantic proximity Read ↗

LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.Semantic proximity Read ↗

Effect of culture media on lymphokine-activated killer effector phenotype and lytic capacity.Semantic proximity Read ↗

Tissue-restricted T cell alloresponses across HLA barriers: selection and identification of leukemia-restricted CTL in HLA-mismatched stimulator-responder pairs.Semantic proximity Read ↗

A novel role for MHC class II antigens: evidence implicating a protective effect on tumour cells against cytotoxicity by NK and LAK cells.Semantic proximity Read ↗

Cytolytic potential of peripheral blood T-lymphocytes following adoptive immunotherapy with lymphokine-activated killer cells and low-dose interleukin 2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.